The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)

The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) is a regional cancer network aimed at reducing prostate, breast and colorectal cancer disparities among adult African Americans in North Carolina. CCN II combines the strengths of the community with resources and research expertise at UNC to reduce cancer disparities through education, research and training.

Based at the University of North Carolina at Chapel Hill, CCN II is comprised of a Research Program, Community Outreach Program, Training Program and Administrative Core.

The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) is supported by the National Cancer Institute's Center to Reduce Cancer Health Disparities through its Community Network Program Centers (U54-CA153602)

No Current Announcements

Older cancer survivors in rural areas are more likely than those in urban areas to forgo medical and dental care because they can't afford it, a new study finds. Researchers analyzed data from more than 7,800 cancer survivors -- 1,642 from rural areas and 6,162 from urban areas -- who took part in the U.S. National Health Interview Surveys between 2006 and 2010. (More...)

Older women who walk every day may reduce their risk of developing breast cancer. And those who exercise vigorously may get even more protection, according to new research. The study of more than 73,000 postmenopausal women found that walking at a moderate pace for an hour a day was associated with a 14 percent reduced breast cancer risk, compared to leading a sedentary lifestyle. An hour or more of daily strenuous physical activity was associated with a 25 percent reduced risk, the study found. (More...)

Changing the Face of Clinical Trials: "Overall, only about 5 to 10 percent of cancer patients participate in clinical trials. And when it comes to African-American cancer patients, the figures are even lower: 2 to 4 percent. This low participation makes it difficult for researchers to get answers to critical questions: Why are African-Americans more likely to develop certain cancers than other racial and ethnic groups and have higher death rates for some types of the disease? Is it lifestyle? Genetics? Treatment response? Access to health care? No one yet knows. But researchers believe that increasing the number of African-Americans in cancer trials will help them find out. So that can happen, more efforts are under way to identify the reasons that so few African-American cancer patients join clinical trials?and to implement programs that can put them on the clinical trials track." (More...)